Annual CFF
$1.16 M
-$3.33 M-74.25%
31 December 2023
Summary:
Virios Therapeutics annual cash flow from financing activities is currently $1.16 million, with the most recent change of -$3.33 million (-74.25%) on 31 December 2023. During the last 3 years, it has fallen by -$32.22 million (-96.54%). VIRI annual CFF is now -96.54% below its all-time high of $33.38 million, reached on 31 December 2020.VIRI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$70.23 K
-$1.52 M-104.84%
30 September 2024
Summary:
Virios Therapeutics quarterly cash flow from financing activities is currently -$70.23 thousand, with the most recent change of -$1.52 million (-104.84%) on 30 September 2024. Over the past year, it has dropped by -$1.23 million (-106.07%). VIRI quarterly CFF is now -100.22% below its all-time high of $31.58 million, reached on 31 December 2020.VIRI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$1.38 M
-$1.23 M-47.02%
30 September 2024
Summary:
Virios Therapeutics TTM cash flow from financing activities is currently $1.38 million, with the most recent change of -$1.23 million (-47.02%) on 30 September 2024. Over the past year, it has increased by +$311.77 thousand (+29.13%). VIRI TTM CFF is now -95.86% below its all-time high of $33.38 million, reached on 31 December 2020.VIRI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIRI Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.3% | -106.1% | +29.1% |
| 3 y3 years | -96.5% | -100.0% | -95.6% |
| 5 y5 years | +0.5% | - | - |
VIRI Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -96.5% | +1284.8% | -101.5% | +18.3% | -95.6% | +1516.2% |
| 5 y | 5 years | -96.5% | +1284.8% | -100.2% | +28.1% | -95.9% | +1516.2% |
| alltime | all time | -96.5% | +1284.8% | -100.2% | +28.1% | -95.9% | +1516.2% |
Virios Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$70.23 K(-104.8%) | $1.38 M(-47.0%) |
| June 2024 | - | $1.45 M(>+9900.0%) | $2.61 M(+125.6%) |
| Dec 2023 | $1.16 M(-74.2%) | $0.00(-100.0%) | $1.16 M(+8.0%) |
| Sept 2023 | - | $1.16 M(>+9900.0%) | $1.07 M(-76.2%) |
| June 2023 | - | $0.00(-100.0%) | $4.49 M(0.0%) |
| Dec 2022 | $4.49 M(-4701.0%) | -$86.00 K(-101.9%) | $4.49 M(-1.9%) |
| Sept 2022 | - | $4.58 M(>+9900.0%) | $4.58 M(>+9900.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$97.60 K(-100.3%) | $0.00(0.0%) | -$97.60 K(-100.3%) |
| Sept 2021 | - | $0.00(0.0%) | $31.48 M(-0.0%) |
| June 2021 | - | $0.00(-100.0%) | $31.49 M(-2.0%) |
| Mar 2021 | - | -$97.60 K(-100.3%) | $32.12 M(-3.8%) |
| Dec 2020 | $33.38 M(+1307.6%) | $31.58 M(>+9900.0%) | $33.38 M(+1756.0%) |
| Sept 2020 | - | $9500.00(-98.5%) | $1.80 M(+0.5%) |
| June 2020 | - | $626.60 K(-46.1%) | $1.79 M(+53.9%) |
| Mar 2020 | - | $1.16 M | $1.16 M |
| Dec 2019 | $2.37 M(+106.1%) | - | - |
| Dec 2018 | $1.15 M | - | - |
FAQ
- What is Virios Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Virios Therapeutics?
- What is Virios Therapeutics annual CFF year-on-year change?
- What is Virios Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Virios Therapeutics?
- What is Virios Therapeutics quarterly CFF year-on-year change?
- What is Virios Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Virios Therapeutics?
- What is Virios Therapeutics TTM CFF year-on-year change?
What is Virios Therapeutics annual cash flow from financing activities?
The current annual CFF of VIRI is $1.16 M
What is the all time high annual CFF for Virios Therapeutics?
Virios Therapeutics all-time high annual cash flow from financing activities is $33.38 M
What is Virios Therapeutics annual CFF year-on-year change?
Over the past year, VIRI annual cash flow from financing activities has changed by -$3.33 M (-74.25%)
What is Virios Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of VIRI is -$70.23 K
What is the all time high quarterly CFF for Virios Therapeutics?
Virios Therapeutics all-time high quarterly cash flow from financing activities is $31.58 M
What is Virios Therapeutics quarterly CFF year-on-year change?
Over the past year, VIRI quarterly cash flow from financing activities has changed by -$1.23 M (-106.07%)
What is Virios Therapeutics TTM cash flow from financing activities?
The current TTM CFF of VIRI is $1.38 M
What is the all time high TTM CFF for Virios Therapeutics?
Virios Therapeutics all-time high TTM cash flow from financing activities is $33.38 M
What is Virios Therapeutics TTM CFF year-on-year change?
Over the past year, VIRI TTM cash flow from financing activities has changed by +$311.77 K (+29.13%)